$0.9600
0.007900.83%
At close: -
$0.9692
0.009250.96%
After Hours: 4:48 PM EDT
Comments
Loading...
Coherus BioSciences Earnings Estimates, EPS & Revenue | NASDAQ:CHRS | Benzinga
Coherus BioSciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.270
Quarterly Revenue Estimate
$49.00M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$266.96M
Analyze the earnings history of Coherus BioSciences using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CHRS | Coherus BioSciences | -$0.32 | -$0.27 | — | — | $77.06M | $49.00M | — | — | 05/08/2025 | Get Alert |
| CHRS | Coherus BioSciences | -$0.62 | -$0.13 | -$0.28 | -115.38% | $91.52M | $43.88M | $54.14M | 23.39% | 03/10/2025 | Get Alert |
| CHRS | Coherus BioSciences | -$0.27 | -$0.12 | -$0.01 | 91.67% | $74.57M | $59.23M | $70.77M | 19.49% | 11/06/2024 | Get Alert |
| CHRS | Coherus BioSciences | -$0.38 | -$0.16 | -$0.14 | 12.50% | $58.72M | $64.16M | $64.98M | 1.28% | 08/08/2024 | Get Alert |
| CHRS | Coherus BioSciences | -$0.75 | -$0.24 | -$0.32 | -33.33% | $32.44M | $80.25M | $77.06M | -3.97% | 05/09/2024 | Get Alert |
| CHRS | Coherus BioSciences | -$0.60 | -$0.12 | -$0.62 | -416.67% | $45.35M | $96.40M | $91.52M | -5.06% | 03/13/2024 | Get Alert |
| CHRS | Coherus BioSciences | -$0.96 | -$0.31 | -$0.27 | 12.90% | $45.42M | $83.56M | $74.57M | -10.76% | 11/06/2023 | Get Alert |
| CHRS | Coherus BioSciences | -$0.47 | -$0.52 | -$0.38 | 26.92% | $60.15M | $50.83M | $58.72M | 15.51% | 08/02/2023 | Get Alert |
| CHRS | Coherus BioSciences | -$1.00 | -$0.57 | -$0.75 | -31.58% | $60.12M | $47.44M | $32.44M | -31.63% | 05/08/2023 | Get Alert |
| CHRS | Coherus BioSciences | -$0.46 | -$0.84 | -$0.60 | 28.57% | $73.37M | $51.22M | $45.35M | -11.46% | 03/06/2023 | Get Alert |
| CHRS | Coherus BioSciences | -$0.34 | -$0.57 | -$0.96 | -68.42% | $82.50M | $56.91M | $45.42M | -20.18% | 11/08/2022 | Get Alert |
| CHRS | Coherus BioSciences | -$0.36 | -$0.65 | -$0.47 | 27.69% | $87.64M | $61.31M | $60.15M | -1.89% | 08/04/2022 | Get Alert |
| CHRS | Coherus BioSciences | $0.01 | -$0.48 | -$1.00 | -108.33% | $83.03M | $68.95M | $60.12M | -12.81% | 05/05/2022 | Get Alert |
| CHRS | Coherus BioSciences | $0.23 | -$0.51 | -$0.46 | 9.80% | $110.42M | $85.81M | $73.37M | -14.50% | 02/17/2022 | Get Alert |
| CHRS | Coherus BioSciences | $0.47 | -$0.22 | -$0.34 | -54.55% | $113.55M | $91.31M | $82.50M | -9.65% | 11/08/2021 | Get Alert |
| CHRS | Coherus BioSciences | $0.81 | -$0.17 | -$0.36 | -111.76% | $135.67M | $89.81M | $87.64M | -2.41% | 08/05/2021 | Get Alert |
| CHRS | Coherus BioSciences | $0.48 | $0.06 | $0.01 | -83.33% | $116.18M | $96.00M | $83.03M | -13.51% | 05/06/2021 | Get Alert |
| CHRS | Coherus BioSciences | $0.53 | $0.23 | $0.23 | 0.00% | $123.86M | $115.12M | $110.42M | -4.08% | 02/24/2021 | Get Alert |
| CHRS | Coherus BioSciences | $0.63 | $0.41 | $0.47 | 14.63% | $111.68M | $122.88M | $113.55M | -7.59% | 11/05/2020 | Get Alert |
| CHRS | Coherus BioSciences | $0.32 | $0.33 | $0.81 | 145.45% | $83.43M | $104.95M | $135.67M | 29.27% | 08/06/2020 | Get Alert |
| CHRS | Coherus BioSciences | -$0.29 | $0.56 | $0.48 | -14.29% | $37.10M | $119.52M | $116.18M | -2.79% | 05/07/2020 | Get Alert |
Coherus BioSciences (CHRS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-10 | $-0.28 | $-0.13 | -115.4 % |
| Q3 | 2024-11-06 | $-0.01 | $-0.12 | 91.7 % |
| Q2 | 2024-08-08 | $-0.14 | $-0.16 | 12.5 % |
| Q1 | 2024-05-09 | $-0.32 | $-0.24 | -33.3 % |
Coherus BioSciences (CHRS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-10 | $54.14M | $43.88M | 23.4 % |
| Q3 | 2024-11-06 | $70.77M | $59.23M | 19.5 % |
| Q2 | 2024-08-08 | $64.98M | $64.16M | 1.28 % |
| Q1 | 2024-05-09 | $77.06M | $80.25M | -3.97 % |
FAQ
When is Coherus BioSciences (NASDAQ:CHRS) reporting earnings?
Coherus BioSciences (CHRS) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 10, 2025 for Q4.
What were the latest earnings per share (EPS) for Coherus BioSciences (NASDAQ:CHRS)?
The Actual EPS was $-0.28, which missed the estimate of $-0.13.
What were Coherus BioSciences’s (NASDAQ:CHRS) revenues?
The Actual Revenue was $54.1M, which beat the estimate of $43.9M.
Browse earnings estimates, EPS, and revenue on all stocks.